Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

67 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Treatment outcome in relation to alcohol consumption during hepatitis C therapy: an analysis of the Swiss Hepatitis C Cohort Study.
Bruggmann P, Dampz M, Gerlach T, Kravecz L, Falcato L. Bruggmann P, et al. Drug Alcohol Depend. 2010 Jul 1;110(1-2):167-71. doi: 10.1016/j.drugalcdep.2010.02.016. Epub 2010 Mar 23. Drug Alcohol Depend. 2010. PMID: 20334985
Adherence to the Swiss guidelines for management of COPD: experience of a Swiss teaching hospital.
Fritsch K, Jacot ML, Klarer A, Wick F, Bruggmann P, Krause M, Thurnheer R. Fritsch K, et al. Among authors: bruggmann p. Swiss Med Wkly. 2005 Feb 19;135(7-8):116-21. Swiss Med Wkly. 2005. PMID: 15832228
Active intravenous drug use during chronic hepatitis C therapy does not reduce sustained virological response rates in adherent patients.
Bruggmann P, Falcato L, Dober S, Helbling B, Keiser O, Negro F, Meili D; Swiss Hepatitis C Cohort Study. Bruggmann P, et al. J Viral Hepat. 2008 Oct;15(10):747-52. doi: 10.1111/j.1365-2893.2008.01010.x. Epub 2008 Jul 10. J Viral Hepat. 2008. PMID: 18637072
Chronic Hepatitis C virus infection in Swiss primary care practices: low case loads-high barriers to treatment?
Overbeck K, Bruggmann P, Helbling B. Overbeck K, et al. Among authors: bruggmann p. Eur J Gen Pract. 2011 Jun;17(2):103-8. doi: 10.3109/13814788.2010.545122. Epub 2011 Apr 26. Eur J Gen Pract. 2011. PMID: 21517703
Management of hepatitis C virus (HCV) infection in drug substitution programs.
Witteck A, Schmid P, Hensel-Koch K, Thurnheer MC, Bruggmann P, Vernazza P; Swiss Hepatitis C and HIV Cohort Studies. Witteck A, et al. Among authors: bruggmann p. Swiss Med Wkly. 2011 May 27;141:w13193. doi: 10.4414/smw.2011.13193. eCollection 2011. Swiss Med Wkly. 2011. PMID: 21623473
Accessing Hepatitis C patients who are difficult to reach: it is time to overcome barriers.
Bruggmann P. Bruggmann P. J Viral Hepat. 2012 Dec;19(12):829-35. doi: 10.1111/jvh.12008. Epub 2012 Oct 1. J Viral Hepat. 2012. PMID: 23205675 Review.
Hepatitis C treatment for multimorbid patients with substance use disorder in a primary care-based integrated treatment centre: a retrospective analysis.
Brunner N, Senn O, Rosemann T, Falcato L, Bruggmann P. Brunner N, et al. Among authors: bruggmann p. Eur J Gastroenterol Hepatol. 2013 Nov;25(11):1300-7. doi: 10.1097/MEG.0b013e32836140bb. Eur J Gastroenterol Hepatol. 2013. PMID: 23571610
Treatment as prevention: the breaking of taboos is required in the fight against hepatitis C among people who inject drugs.
Bruggmann P. Bruggmann P. Hepatology. 2013 Nov;58(5):1523-5. doi: 10.1002/hep.26539. Epub 2013 Sep 17. Hepatology. 2013. PMID: 23728921 No abstract available.
Models of care for the management of hepatitis C virus among people who inject drugs: one size does not fit all.
Bruggmann P, Litwin AH. Bruggmann P, et al. Clin Infect Dis. 2013 Aug;57 Suppl 2(Suppl 2):S56-61. doi: 10.1093/cid/cit271. Clin Infect Dis. 2013. PMID: 23884067 Free PMC article. Review.
QTc prolongation in methadone maintenance--the role of HCV infection.
Gholami N, Boesch L, Falcato L, Stohler R, Bruggmann P. Gholami N, et al. Among authors: bruggmann p. Swiss Med Wkly. 2013 Sep 6;143:w13852. doi: 10.4414/smw.2013.13852. eCollection 2013. Swiss Med Wkly. 2013. PMID: 24018830
67 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback